Dava Oncology — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

DAVA Oncology is a private, services-oriented company that functions as a specialized medical education and conference organizer within the oncology space. Unlike biotech firms developing therapeutics, DAVA's core business is facilitating knowledge exchange through summits focused on hematologic, thoracic, breast, gastrointestinal, and genitourinary malignancies. The company appears to be revenue-generating, with income derived from attendee registrations for its multi-day events held at premium locations. Led by a board-certified oncologist, DAVA leverages its founder's clinical and prior medical education experience to build a network aimed at bridging the gap between academic advances and community practice.

Oncology

Technology Platform

Curated network and operational expertise for organizing high-end, sub-specialty focused oncology summits and educational forums.

Opportunities

The rapid expansion of complex oncology data and treatments creates a sustained, growing demand for specialized physician education.

DAVA can leverage its established summit brands to expand into adjacent educational formats, such as digital content or regional workshops, and potentially deepen partnerships with pharmaceutical companies for sponsored symposia.

Risk Factors

The business is highly vulnerable to travel disruptions, economic downturns, and regulatory changes affecting industry-sponsored medical education.

Competition from other medical education providers and professional societies is significant, and the model relies heavily on the continued participation of key opinion leaders to maintain event prestige and attendance.

Competitive Landscape

DAVA Oncology competes with other for-profit medical education companies (like its founder's prior venture, Physician’s Education Resource), large professional societies (ASCO, ESMO, ASH), and pharmaceutical company-sponsored advisory boards and symposia. Its differentiation lies in the sub-specialty focus, destination setting, and curated interactive format of its flagship summits.

More companies in Oncology (General) →More companies in United States →